R&D Spin-outs in the pharmaceutical industry

The high number of research and development (R&D) spin-outs in the pharmaceutical industry during the last 10 years focusing on drug development or offering specialised services demonstrates that pharmaceutical companies believe, through doing this, they can improve R&D performance....

Authors: Festel, Gunter
De Cleyn, Sven H.
Division/Institute:FB 12: Chemie und Pharmazie
Document types:Article
Media types:Text
Publication date:2011
Date of publication on miami:05.08.2012
Modification date:18.03.2016
Source:Journal of Business Chemistry, 8 (2011) 3, S. 101-113
Edition statement:[Electronic ed.]
DDC Subject:330: Wirtschaft
License:InC 1.0
Language:English
Notes:Section "Research Paper"
Format:PDF document
URN:urn:nbn:de:hbz:6-79379590027
Permalink:http://nbn-resolving.de/urn:nbn:de:hbz:6-79379590027
Digital documents:2011_vol-8_iss3_101-113.pdf
Loading...